India
· Delayed Price · Currency is INR Poly Medicure Statistics
Total Valuation
Poly Medicure has a market cap or net worth of INR 261.61 billion. The enterprise value is 250.70 billion.
| Market Cap | 261.61B |
| Enterprise Value | 250.70B |
Important Dates
The last earnings date was Tuesday, October 22, 2024.
| Earnings Date | Oct 22, 2024 |
| Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | +1.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 31.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 61.28, with an EV/FCF ratio of -460.78.
| EV / Earnings | 85.02 |
| EV / Sales | 16.47 |
| EV / EBITDA | 61.28 |
| EV / EBIT | 74.34 |
| EV / FCF | -460.78 |
Financial Position
The company has a current ratio of 4.61, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.61 |
| Quick Ratio | 3.79 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | -2.95 |
| Interest Coverage | 26.33 |
Financial Efficiency
Return on equity (ROE) is 15.01% and return on invested capital (ROIC) is 9.91%.
| Return on Equity (ROE) | 15.01% |
| Return on Assets (ROA) | 8.82% |
| Return on Capital (ROIC) | 9.91% |
| Revenue Per Employee | 2.42M |
| Profits Per Employee | 468,044 |
| Employee Count | 6,300 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 2.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.99% in the last 52 weeks. The beta is 0.36, so Poly Medicure's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +69.99% |
| 50-Day Moving Average | 2,533.10 |
| 200-Day Moving Average | 1,992.08 |
| Relative Strength Index (RSI) | 46.29 |
| Average Volume (20 Days) | 245,921 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Poly Medicure had revenue of INR 15.22 billion and earned 2.95 billion in profits. Earnings per share was 30.63.
| Revenue | 15.22B |
| Gross Profit | 10.08B |
| Operating Income | 3.35B |
| Pretax Income | 3.97B |
| Net Income | 2.95B |
| EBITDA | 4.06B |
| EBIT | 3.35B |
| Earnings Per Share (EPS) | 30.63 |
Balance Sheet
The company has 12.51 billion in cash and 1.61 billion in debt, giving a net cash position of 10.91 billion.
| Cash & Cash Equivalents | 12.51B |
| Total Debt | 1.61B |
| Net Cash | 10.91B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.91B |
| Book Value Per Share | 266.96 |
| Working Capital | 15.07B |
Cash Flow
In the last 12 months, operating cash flow was 2.53 billion and capital expenditures -3.07 billion, giving a free cash flow of -544.08 million.
| Operating Cash Flow | 2.53B |
| Capital Expenditures | -3.07B |
| Free Cash Flow | -544.08M |
| FCF Per Share | n/a |
Margins
Gross margin is 66.23%, with operating and profit margins of 22.01% and 19.37%.
| Gross Margin | 66.23% |
| Operating Margin | 22.01% |
| Pretax Margin | 26.06% |
| Profit Margin | 19.37% |
| EBITDA Margin | 26.64% |
| EBIT Margin | 22.01% |
| FCF Margin | -3.57% |
Dividends & Yields
Poly Medicure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 9.74% |
| Buyback Yield | -0.24% |
| Shareholder Yield | -0.24% |
| Earnings Yield | 1.19% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 24, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 24, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |